Welcome to the new Boehringer Ingelheim Blog!

Embed from Getty Images

About our new blog

What topics will we write about?

This blog will not be promotional of our medicines. We want it to be a forum for discussing issues we think are important to our patients, our company, our industry and the broader healthcare sector.

Who’s blogging?

Initially, posts will come from our new Medical Director, Prof. Klaus Dugi, our Communications Director, Duncan Cantor and our Head of Public Affairs and Patient Advocacy, Alan Sumner. Want to know more about our authors? Check out our Authors Page for biographies.

Depending on the topic, other authors will join in. And of course, we would love to hear from you either by commenting on our posts, connecting on social media or by being a guest blogger. If you’d like to write a guest post, please get in touch!

About Boehringer Ingelheim

Boehringer Ingelheim is dedicated to the research and development of medical products to improve, sustain and care for life.

Boehringer Ingelheim was founded in 1885 by Albert Boehringer and remains a family-owned company. Today we are amongst the world’s 20 leading pharmaceutical companies. You can find out more about our company here. You can also find out more about our medicines here and our patients here.

In Short

  • We are committed to improving patients’ lives and our quest for innovation and medical breakthrough is the driver of our business.
  • We have always been at the cutting edge of research & development and have developed leading treatments in a range of therapeutic areas.
  • We believe our employees are our biggest asset and regularly feature in the ‘Sunday Times Top 100 Best Companies to Work For’ survey.